"There & (1983) (2001). (2008) (2009) (2011). (2012) (2012), (2012). (2013) (2014) (2014), (2015), (2015). (2017). (2018) (2018). (Accessed (Aggarwal, (Baron, (Bridgeman (Busby, (Caldwell, (Clifford, (Cohen, (Curtis (Department (Dos (Esther (Flynn, (HM (Hill (Kraft, (Nutt, (Parahoo, (Pertwee, (Raichlen, (Robson (Scheidweiler (THC), (UK) (US), (WHO, (cited (dos (pp. 1) 1-7. 1/6/18). 12-43. 13, 133, 15). 15, 15‐20 162‐171 180. 1971, 1983), 2.5% 20 2001). 2006 2008). 2008: 2009), 2010), 2011), 2012) 2012), 2012). 2012; 2013) 2013), 2014 2014) 2014). 2015), 2015). 2015; 2016). 2017). 2018). 2018; 2019) 2019), 2254‐2259. 24, 29 29, 3(5), 31(8), 38 40. 42(3), 5. 55(6), 669‐671. 71% 78 79‐97 8(3), 885-916. 939-946). A A. A., A.J., Abazia, According Across Act Acute Adolescent Aggarwal, Aghazadeh Ahrens, Alfie Alfie's And Annals As B., B.J., Baron Baron, Beauchamp Beauchamp, Brain Bridgeman, Busby, By C., C.M., CNS Caldwell, Cambridge Cannabidiol Cannabinergic Cannabis Cannabis, Cannabis: Care Caroline Childress, Choo, Clifford, Clinical Coggon Coggon, Cohen, Comprehensive Constitution. Controlled Crippa, Curtis, D. D.B. Delta‐9 Department Despite Developing Dingley, Disorder. Disorders. Dos Drug E. EU Education Esther Esther, Europe European F. Face Flynn Flynn, French Further G. G., G.J. GOV, Germany, H. HMSO. Hallak, Handbook Head Headache: Health Health, Henshaw, High Hill, History, Home However, Huntington's I., Impact Implications In Initial It's Italy, Ives, J. Journal K. K., Karst, Kingdom L., Legalise Legislation London: Lucas, Lung M. M.B., MS, Marijuana McCartan, McConnell., Medical Medicinal Mitchell, Mov N., NGS NHS Netherlands, Neurology. Nurse Nutt, Organization Oxford Oxford: P. PCDH19, Pain, Pain. Parahoo, Parkinson’s Patel, Pathologies Pharmacological Pharmacology, Pharmacy Phytocannabinoids Portugal, Press. Principles R. RCT Randomized References Related Report Retrieved Rickards, Rising, S., S.K. Santos Santos, Sativex Sciences, Setting. Social Souza Spain, State State. States Stephens, T. THC Tabrizi, Taylor, Tetrahydrocannabinol The Therapeutics, Therapy. There Therefore, These This Thus, Time Today, Treatment Trials Tsakyrakis UK UK, UK. US US, United Unites University Use Use. W., Warren, Weinstein, Whalley, What Why Williams, Wippermann, World Zaller, Zuardi, [60‐120 [RCTs] [THC] [around] a able absorbed abuse abused, access account acknowledged across actively addiction addiction, addiction. addressed. adults agents aiding al. al.’s aligned all allodynia, also alter alternative although always an analgesic analysis, and anecdotal, any application applications approach are areas as asserts assessed associated assuming at autonomy balance banned; base based basis be because been been. being believe beneficial benefits benefits, best between biomedical blind body body, both bound brain brains. breaches build but buy by calls can cancer, cannabinoids cannabinoids, cannabinoids—a cannabinoid–opioid cannabis cannabis, cannabis,". cannabis-based cardiovascular-related care care, care. career case cases causing certain changes, changing choice choice, choose chronic claims clinical codeine’s collating combined common commonly comparable complications compound compounds concern concise conclusion, condition condition. conditions conditions, conditions. conducting consider considered consumed contains contradictory controlling cope correlated correlation, could countries, criminal criminalizing critical critiquing cultivated data data, de death debates decision-making decisions, delta-9-tetrahydrocannabinol demonstrate demonstrates demonstrating dependency, describes despite determined determining detrimental developing diagnosed differences difficult direct directly discharge disease disease. disorders disorders. distorting doctor’s dose doses, drug due duty each early eaten effect, effects effects, efficacy emotions empirical employing enable enhance epilepsy equally essay et ethical ethics. evaluation evaluation. even evidence evidence, evidenced evidencing examining executive experienced experiences explores extent, eye face facilitate factors fats, findings five for foster fostering four framework from from: functions: gaining globally growing has have having headache: headaches health health(Vol. highlights history how how, however however, https://www.vice.com/en_uk/article/wj4pvx/its-high-time-to-legalise-medicinal-cannabis-in-the-uk hyperalgesia ignore ill-health illegal illegal, illegal. illicit impedes implications improving in include included including inconsistency increase indicates indicating individual individually individuals individuals’ inept. inequalities inform interaction interestingly, interests intervention into ironically, is is, issue. issues issues, it it's its itself just know knows l laboratory‐based lacks law law, laws leading legal legal, legalise legalising legalization legalize legalized legalizing legally licensed life life, life. like likely limitations limited line linked literature lives lives, living long long-term makes making management management, managing many many, marijuana marijuana, may medical medicinal medicine medicine: method methodological methods mg mg] middle-aged minutes, missing month moral moral, more most motivation. much multiple must must, nabilone named narcotics, need needlessly needs negative no not noted notes notes, notoriously novel now number of off offence. offences, offer office officer’s oil on one oneHealth opiates; opinion opioid opioid‐sparing opposed or other overcomes own pain pain‐reduction, particularly parts patient patients patients’ patient’s people people. people’s percent perception person-centred physical physiological pilot place; plans, play pleasurable, police policewoman policies policy, political poll poor population population, possesses possession potential power, practice practice, preferences prescribed prescribed, prescribing prescription present pressure prevalence prevented primer privately product prohibiting prone properties prosecutors psychoactive psychological public public?: purposes quality quantitative questioned raises. randomized‐controlled rate rates real recognized recreational reduce reducing refutes regarded regardless reinstated relation relevance reliability reliability. reliant remaining rendering reported reporting reports requires research research, research: responses results. retrospective revealed review review. risk risk, risks role safeguarding sample samples scientific sclerosis sclerosis. see seizures self-management severe should shown side significant similar single six six-year-old sizes skin, small smoked smoked, smokers somewhat state state-imposed, states states, statistical strange strives studies, studies’ study subjective such suffering suggest supports suppressing surrounding survey symptomatic symptoms synthetic systematic term terms that the their therapeutic there therefore they this this, this. three through throughout thus to toxicity trafficked, trafficking treatment tremor trial triggered triggers trip turn two understood unethical, unreliable until up uphold use use, used, using validity value very views was we weakness weaning well were what when where whether which whilst who whose will with with, within without world would year. years young – ‘Sativex’, ‘health’